TerminatedNo phase
Fluid Biopsy for the Diagnosis of Lung Cancer
Key facts
- Who runs it
- University of Southern California
- Where
- Los Angeles, United StatesSee the 2 sites
- Trial code
- Status
- Terminated
- People taking part
- 51 people enrolled
- Started
- 13 Jan 2020
- Ended
- 9 Dec 2024
- Type of study
- Observational
- Treatments tested
- Biospecimen Collection
- Laboratory Biomarker Analysis
- Liquid Biopsy
- Medical Chart Review
- Record updated
- 5 September 2025
- Why it stopped
- insufficient accrual
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Scheduled to undergo a diagnostic biopsy for possible lung cancer or
- Completed a diagnostic lung cancer biopsy in the prior 2 weeks and has not yet undergone treatment or
- Planning or completed in the last 2 weeks a CT lung cancer screen
- Ability to understand and the willingness to sign a written informed consent
Who cannot take part
- Patients who have had chemotherapy or radiotherapy within 4 weeks prior to entering the study
- Known other solid tumor malignancy other than lung cancer requiring ongoing active treatment
Where in United States
- Los Angeles County-USC Medical CenterLos Angeles, United StatesNo longer taking part
- USC / Norris Comprehensive Cancer CenterLos Angeles, United StatesNo longer taking part
About the trial
What the trial wants to find out
This trial collects and studies blood samples via fluid biopsy for the diagnosis of lung cancer. Studying blood samples in the laboratory may help doctors develop a blood test for lung cancer in the future and provide a better way to screen patients for lung cancer.
The group in the trial
- Diagnostic (blood collection via fluid biopsy, lab analysis)
Patients undergo collection of blood samples on day 1 for analysis via HD-SCA fluid biopsy. Medical charts of patients are reviewed at 3 months post-biopsy or CT screening.
Treatment: Biospecimen Collection, Laboratory Biomarker Analysis, Liquid Biopsy, and Medical Chart Review
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Establishing a Diagnosis of Lung Cancer Through a Fluid Biopsy
- Record updated
- 5 September 2025